| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/13/2009 | WO2009100140A1 Anti-clta-4 antibodies with reduced blocking of binding of ctla-4 to b7 and uses thereof |
| 08/13/2009 | WO2009100135A2 Hla-g compositions and methods of use thereof |
| 08/13/2009 | WO2009100110A1 Alpha 5 - beta 1 antibodies and their uses |
| 08/13/2009 | WO2009099991A2 Treatment of cancer |
| 08/13/2009 | WO2009099829A1 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof |
| 08/13/2009 | WO2009099728A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 08/13/2009 | WO2009099716A1 Novel vaccines against multiple subtypes of dengue virus |
| 08/13/2009 | WO2009099678A1 Influenza b vaccines |
| 08/13/2009 | WO2009099672A2 Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 08/13/2009 | WO2009099545A1 Compositions and methods for crystallizing antibody fragments |
| 08/13/2009 | WO2009099377A1 Treatment of idiopathic thrombocytopenic purpura |
| 08/13/2009 | WO2009099176A1 Antibody capable of binding specifically to aβ-oligomer, and use thereof |
| 08/13/2009 | WO2009099147A1 Il-1 type ii receptor gene-deficient mutant of mouse |
| 08/13/2009 | WO2009098592A2 Preparation comprising mycobacterium bovis bcg killed by extended freeze drying (efd) for preventing or treating rheumatoid arthritis. |
| 08/13/2009 | WO2009098410A1 Leporipoxvirus-derived vaccine vectors |
| 08/13/2009 | WO2009098238A1 Anti-trka antibodies and derivatives thereof |
| 08/13/2009 | WO2009097704A1 Antigen-binding polypeptides against cartilage degeneration |
| 08/13/2009 | WO2009081274A3 Mutant forms of streptolysin o |
| 08/13/2009 | WO2009077993A3 Treatment of interstitial cystitis |
| 08/13/2009 | WO2009071613A3 Vaccine |
| 08/13/2009 | WO2009050573A3 Viral modification of reoviridae |
| 08/13/2009 | WO2009031043A3 Compositions comprising yersinia pestis antigens |
| 08/13/2009 | WO2009016515A3 Compositions comprising pneumococcal antigens |
| 08/13/2009 | WO2009016456A3 Idiotypic vaccine |
| 08/13/2009 | WO2009001217A3 Low-additive influenza vaccines |
| 08/13/2009 | WO2008066854A3 Methods and compositions for inducing apoptosis in cancer cells |
| 08/13/2009 | WO2006085979A9 Soluble forms of hendra and nipah virus g glycoprotein |
| 08/13/2009 | US20090205062 Caspase-9 deficient animals and the use thereof |
| 08/13/2009 | US20090205056 Method of screening for modulators of map3k11 in liver cancer cells |
| 08/13/2009 | US20090204489 Biological markers predictive of rheumatoid arthritis response to b-cell antagonists |
| 08/13/2009 | US20090203842 Macromolecular Conjugates And Processes For Preparing The Same |
| 08/13/2009 | US20090203144 Hiv-gag codon-optimised dna vaccines |
| 08/13/2009 | US20090203114 Novel methods and interferon deficient substrates for the propagation of viruses |
| 08/13/2009 | US20090203113 comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; drug delivery |
| 08/13/2009 | US20090203044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/13/2009 | US20090203036 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 08/13/2009 | US20090203033 Test and model for alzheimer's disease |
| 08/13/2009 | US20090203024 Secreted protein called 36p6d5 characteristic of tumors |
| 08/13/2009 | US20090202651 Antigen specific fluorescent nanoparticles |
| 08/13/2009 | US20090202642 Drug Delivery System Comprising Microparticles and Gelation System |
| 08/13/2009 | US20090202638 Bmp gene and fusion protein |
| 08/13/2009 | US20090202627 Methods and compositions for diseases associated with amyloidosis |
| 08/13/2009 | US20090202622 Virosome-like vesicles comprising gp41-derived antigens |
| 08/13/2009 | US20090202620 Polymer-stabilized liposomal compositions and methods of use |
| 08/13/2009 | US20090202618 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 08/13/2009 | US20090202595 Anti-pdef antibodies and uses thereof |
| 08/13/2009 | US20090202594 Anti-bacterial Vaccine Compositions |
| 08/13/2009 | US20090202593 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/13/2009 | US20090202592 Cytolethal distending toxin, inhibition and use thereof |
| 08/13/2009 | US20090202591 Leucine-based motif and clostridial neurotoxins |
| 08/13/2009 | US20090202590 Influenza vaccines extemporaneously adsorbed to aluminium adjuvants |
| 08/13/2009 | US20090202589 Fermenter system for biotechnical processes |
| 08/13/2009 | US20090202588 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 08/13/2009 | US20090202587 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof |
| 08/13/2009 | US20090202586 Attenuated vaccine for tularemia |
| 08/13/2009 | US20090202585 Tat-based tolerogen compositions and methods for making and using same |
| 08/13/2009 | US20090202584 Treatment of epstein-barr virus-associated diseases |
| 08/13/2009 | US20090202583 Rhinovirus Vaccines |
| 08/13/2009 | US20090202580 Method for the preparation of specific antibodies against saccharidic antigens |
| 08/13/2009 | US20090202579 Methods and compositions for treating and preventing malaria (2) |
| 08/13/2009 | US20090202578 Surface proteins from coagulase-negative staphylococci and staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
| 08/13/2009 | US20090202577 CASB618 Polynucleotides and Polypeptides and Their Use |
| 08/13/2009 | US20090202576 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202574 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 08/13/2009 | US20090202573 Polymeric conjugates containing positively-charged moieties |
| 08/13/2009 | US20090202572 Compositions and methods for modulating bone mass |
| 08/13/2009 | US20090202571 Bioreductively-activated prodrugs |
| 08/13/2009 | US20090202570 Pm-2 antibodies, functional fragments and methods for treating metastasis |
| 08/13/2009 | US20090202569 Prophylactic/Therapeutic Agent for Cancer |
| 08/13/2009 | US20090202568 Binding members for interleukin-4 receptor alpha (IL-4Ra)-173 |
| 08/13/2009 | US20090202567 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm |
| 08/13/2009 | US20090202566 Use of the ENDO-180 gene and polypeptide for diagnosis and treatment |
| 08/13/2009 | US20090202565 Torc polynucleotides and polypeptides and method of use |
| 08/13/2009 | US20090202564 Methods of isolating stem cells |
| 08/13/2009 | US20090202563 C20ORF23 as modifier of the IGFR pathway and methods of use |
| 08/13/2009 | US20090202562 Anti-gfralpha3 antibodies |
| 08/13/2009 | US20090202561 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/13/2009 | US20090202560 Method for diagnosing efficacy of xenotypic antibody therapy |
| 08/13/2009 | US20090202559 conjugated drug for drug targeting at pancreatic cancer cell; biodrugs as antitumor agent, anticarcinogenic agent; free of side effect |
| 08/13/2009 | US20090202558 TNFalpha-NEUTRALIZING ANTIBODIES |
| 08/13/2009 | US20090202557 Compositions and methods for crystallizing antibody fragments |
| 08/13/2009 | US20090202556 Anti-claudin-4 antibody |
| 08/13/2009 | US20090202555 Antibodies against a peptide epitope of apoliporotein b |
| 08/13/2009 | US20090202554 Method of modulation of interaction between receptor and ligand |
| 08/13/2009 | US20090202553 Antibodies against anthrax protective antigen |
| 08/13/2009 | US20090202552 Gene expressed in prostate cancer and methods of use |
| 08/13/2009 | US20090202551 Immunomodulation by altering sphingosine 1-phosphate lyase (spl) activity |
| 08/13/2009 | US20090202550 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 08/13/2009 | US20090202549 Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses |
| 08/13/2009 | US20090202548 Antibodies and related molecules that bind to psca proteins |
| 08/13/2009 | US20090202547 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 08/13/2009 | US20090202546 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof |
| 08/13/2009 | US20090202545 Melanoma biomarker and methods of uses |
| 08/13/2009 | US20090202544 Methods of Treating Diseases by Targeting Silt3 |
| 08/13/2009 | US20090202543 Gene and polypeptide relating to breast cancer |
| 08/13/2009 | US20090202542 Rage protein derivatives |
| 08/13/2009 | US20090202541 Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl)-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 08/13/2009 | US20090202540 Substituted oxazaphosphorines |
| 08/13/2009 | US20090202539 METHOD FOR TREATING CANCER USING ANTI-WNT2 MONOCLONAL ANTIBODIES AND siRNA |